🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/12/1992 | 0,1193 USD |
| 31/08/1992 | 0,1193 USD |
| 02/06/1992 | 0,1097 USD |
| 02/03/1992 | 0,1097 USD |
| 02/12/1991 | 0,1002 USD |
| 30/08/1991 | 0,1002 USD |
| 03/06/1991 | 0,0891 USD |
| 04/03/1991 | 0,0891 USD |
| 03/12/1990 | 0,0891 USD |
| 28/08/1990 | 0,0891 USD |
| 29/05/1990 | 0,0716 USD |
| 05/03/1990 | 0,0716 USD |
| 04/12/1989 | 0,0716 USD |
| 29/08/1989 | 0,0716 USD |
| 30/05/1989 | 0,0652 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/11/2021 | 81,00 | 82,07 | 80,54 | 81,64 | +1,16% | 1,89% | 10.880.200 |
| 19/11/2021 | 82,37 | 82,75 | 80,62 | 80,70 | -2,83% | 2,59% | 17.581.100 |
| 18/11/2021 | 82,30 | 83,14 | 82,02 | 83,05 | +0,54% | 1,36% | 9.833.600 |
| 17/11/2021 | 84,37 | 84,67 | 82,59 | 82,60 | -1,80% | 2,47% | 10.286.300 |
| 16/11/2021 | 83,67 | 84,69 | 83,25 | 84,11 | +0,50% | 1,72% | 10.565.200 |
| 15/11/2021 | 84,15 | 84,18 | 83,40 | 83,69 | -0,37% | 0,93% | 7.108.200 |
| 12/11/2021 | 83,84 | 84,20 | 83,05 | 84,00 | -0,02% | 1,37% | 8.206.700 |
| 11/11/2021 | 83,92 | 84,26 | 83,53 | 84,02 | +0,01% | 0,87% | 5.761.500 |
| 10/11/2021 | 83,31 | 84,02 | 82,70 | 84,01 | +1,56% | 1,58% | 9.855.900 |
| 09/11/2021 | 83,62 | 83,71 | 81,91 | 82,72 | +0,05% | 2,15% | 10.512.000 |
| 08/11/2021 | 80,41 | 82,88 | 79,88 | 82,68 | +1,31% | 3,73% | 18.655.700 |
| 05/11/2021 | 82,29 | 84,00 | 81,35 | 81,61 | -9,86% | 3,22% | 37.623.900 |
| 04/11/2021 | 90,37 | 91,40 | 89,27 | 90,54 | +2,10% | 2,36% | 19.519.800 |
| 03/11/2021 | 88,77 | 89,42 | 88,21 | 88,68 | -0,38% | 1,36% | 10.883.900 |
| 02/11/2021 | 88,23 | 90,42 | 87,48 | 89,02 | +1,34% | 3,33% | 14.671.400 |
| 01/11/2021 | 88,05 | 88,63 | 87,29 | 87,84 | -0,24% | 1,52% | 10.943.900 |
| 29/10/2021 | 86,49 | 88,46 | 86,17 | 88,05 | +1,73% | 2,65% | 18.678.600 |
| 28/10/2021 | 83,38 | 86,86 | 83,17 | 86,55 | +6,14% | 4,43% | 28.854.700 |
| 27/10/2021 | 82,48 | 82,48 | 81,30 | 81,54 | -0,86% | 1,43% | 8.465.400 |
| 26/10/2021 | 81,90 | 82,36 | 81,71 | 82,25 | +0,72% | 0,79% | 9.352.500 |
| 25/10/2021 | 81,03 | 81,72 | 79,95 | 81,66 | +0,63% | 2,18% | 9.365.900 |
| 22/10/2021 | 81,15 | 81,48 | 80,88 | 81,15 | -0,02% | 0,74% | 7.543.600 |
| 21/10/2021 | 81,11 | 81,26 | 80,28 | 81,17 | +0,12% | 1,21% | 9.893.600 |
| 20/10/2021 | 79,32 | 81,25 | 79,31 | 81,07 | +1,99% | 2,45% | 11.465.500 |
| 19/10/2021 | 78,73 | 79,52 | 78,11 | 79,49 | +3,03% | 1,79% | 15.577.100 |
| 18/10/2021 | 78,74 | 78,74 | 77,11 | 77,15 | -1,51% | 2,07% | 13.075.500 |
| 15/10/2021 | 78,20 | 79,06 | 77,98 | 78,33 | +0,00% | 1,38% | 12.866.800 |
| 14/10/2021 | 78,97 | 79,67 | 77,98 | 78,33 | -0,79% | 2,14% | 14.607.900 |
| 13/10/2021 | 79,59 | 79,66 | 78,78 | 78,95 | -0,80% | 1,11% | 9.462.600 |
| 12/10/2021 | 80,18 | 80,18 | 79,25 | 79,59 | -0,43% | 1,16% | 10.945.000 |